Detalles de la búsqueda
1.
Significance of the autoantibody assay in predicting the development of immune-related adverse events in patients receiving atezolizumab plus bevacizumab combination therapy for unresectable hepatocellular carcinoma.
Hepatol Res
; 54(2): 162-173, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37740643
2.
Risk of hepatocellular carcinoma after viral clearance achieved by DAA treatment.
J Formos Med Assoc
; 2024 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38245398
3.
Prediction of Therapeutic Response Using Contrast-Enhanced Ultrasound in Japanese Patients Treated with Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma.
Oncology
; 101(3): 173-184, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36516803
4.
Relationship between Plasma IP-10/CXCL10 Levels and the Initial Therapeutic Response in Patients Treated with Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
Oncology
; 101(10): 655-663, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37379802
5.
Impact of Renal Function on the Prognosis of Patients Receiving Atezolizumab/Bevacizumab Combination Therapy and Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma.
Oncology
; 101(10): 609-623, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37279708
6.
Significance of serum IP-10/CXCL10 measurement in predicting post-direct acting antiviral treatment liver function in patients with HCV-decompensated liver cirrhosis.
Hepatol Res
; 53(4): 280-288, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36445119
7.
Early diagnosis of hepatic inflammation in Japanese nonalcoholic fatty liver disease patients using 3D MR elastography.
Hepatol Res
; 53(3): 208-218, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36372908
8.
Effect of a combination of pemafibrate and a mild low-carbohydrate diet on obese and non-obese patients with metabolic-associated fatty liver disease.
J Gastroenterol Hepatol
; 38(6): 921-929, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36811251
9.
Next-generation sequencing of endoscopically obtained tissues from patients with all stages of pancreatic cancer.
Cancer Sci
; 113(3): 1069-1077, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34962016
10.
Stepwise correlation of TP53 mutations from pancreaticobiliary maljunction to gallbladder carcinoma: a retrospective study.
BMC Cancer
; 21(1): 1245, 2021 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34798839
11.
Deep sequencing analysis of serum hepatitis B virus-RNA during nucleot(s)ide analogue therapy.
Hepatol Res
; 51(1): 39-50, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32961003
12.
MiR-10a in Pancreatic Juice as a Biomarker for Invasive Intraductal Papillary Mucinous Neoplasm by miRNA Sequencing.
Int J Mol Sci
; 22(6)2021 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-33809988
13.
Cancer-related genetic changes in multistep hepatocarcinogenesis and their correlation with imaging and histological findings.
Hepatol Res
; 50(9): 1071-1082, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32510681
14.
Form-Vessel Classification of Cholangioscopy Findings to Diagnose Biliary Tract Carcinoma's Superficial Spread.
Int J Mol Sci
; 21(9)2020 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32392821
15.
Identification of early genetic changes in well-differentiated intramucosal gastric carcinoma by target deep sequencing.
Gastric Cancer
; 22(4): 742-750, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30756200
16.
Hepatitis B virus (HBV)-infected patients with low hepatitis B surface antigen and high hepatitis B core-related antigen titers have a high risk of HBV-related hepatocellular carcinoma.
Hepatol Res
; 49(1): 51-63, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30350374
17.
Comprehensive genetic analysis of cholangiolocellular carcinoma with a coexistent hepatocellular carcinoma-like area and metachronous hepatocellular carcinoma.
Hepatol Res
; 49(12): 1466-1474, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31261448
18.
Deep sequencing and phylogenetic analysis of variants resistant to interferon-based protease inhibitor therapy in chronic hepatitis induced by genotype 1b hepatitis C virus.
J Virol
; 89(11): 6105-16, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25810555
19.
Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C.
Hum Genet
; 134(3): 279-89, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25515861
20.
Hallmarks of hepatitis C virus in equine hepacivirus.
J Virol
; 88(22): 13352-66, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25210167